Progress in the development of RBC substitutes

被引:92
作者
Stowell, CP
Levin, J
Spiess, BD
Winslow, RM
机构
[1] Massachusetts Gen Hosp, Blood Transfus Serv, Boston, MA 02114 USA
[2] Univ Calif San Francisco, Sch Med, Dept Lab Med, San Francisco, CA 94143 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Div Cardiothorac Anesthesia, Richmond, VA 23298 USA
[4] Sangart Inc, San Diego, CA USA
关键词
D O I
10.1046/j.1537-2995.2001.41020287.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:287 / 299
页数:13
相关论文
共 94 条
[51]   New variant Creutzfeldt-Jakob Disease (nvCJD): The risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components [J].
Murphy, MF .
TRANSFUSION MEDICINE REVIEWS, 1999, 13 (02) :75-83
[52]   PEG-HEMOGLOBIN - AN EFFICIENT OXYGEN-DELIVERY SYSTEM IN THE RAT EXCHANGE-TRANSFUSION AND HYPOVOLEMIC SHOCK-MODELS [J].
NHO, K ;
LINBERG, R ;
JOHNSON, M ;
GILBERT, C ;
SHORR, R .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (03) :795-803
[53]   Absence of immunogenicity of diaspirin cross-linked hemoglobin in humans [J].
Patel, MJ ;
Webb, EJ ;
Shelbourn, TE ;
Mattia-Goldberg, C ;
George, AJT ;
Zhang, F ;
Moore, EG ;
Nelson, DJ .
BLOOD, 1998, 91 (02) :710-716
[54]  
Phillips WT, 1999, J PHARMACOL EXP THER, V288, P665
[55]   Use of oxygen-15 to measure oxygen-carrying capacity of blood substitutes in vivo [J].
Phillips, WT ;
Lemen, L ;
Goins, B ;
Rudolph, AS ;
Klipper, R ;
Fresne, D ;
Jerabek, PA ;
Emch, ME ;
Martin, C ;
Fox, PT ;
McMahan, CA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (05) :H2492-H2499
[56]   Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution [J].
Przybelski, RJ ;
Daily, EK ;
Kisicki, JC ;
MattiaGoldberg, C ;
Bounds, MJ ;
Colburn, WA .
CRITICAL CARE MEDICINE, 1996, 24 (12) :1993-2000
[57]  
PRZYBELSKI RJ, 1997, ADV BLOOD SUBSTITUTE, P71
[58]   LYOPHILIZED LIPOSOME-ENCAPSULATED HEMOGLOBIN - EVALUATION OF HEMODYNAMIC, BIOCHEMICAL, AND HEMATOLOGIC RESPONSES [J].
RABINOVICI, R ;
RUDOLPH, AS ;
VERNICK, J ;
FEUERSTEIN, G .
CRITICAL CARE MEDICINE, 1994, 22 (03) :480-485
[59]  
Rabinovici R., 1998, RED BLOOD CELL SUBST, P263
[60]  
RATTAN S, 1995, J PHARMACOL EXP THER, V272, P1211